Journal of Clinical Gastroenterology and Hepatology Open Access

  • ISSN: 2575-7733
  • Journal h-index: 5
  • Journal CiteScore: 0.63
  • Journal Impact Factor: 0.41
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Efficacy of MGB in diabetic patients with body mass index <35 kg/m2

6th Annual European Conference on Gastroenterology
June 19-20, 2018 Paris, France

Waleed Gado and T Mahdy

Mansoura University, Egypt
Al Qassimi Hospital, UAE

Scientific Tracks Abstracts: J Clin Gastroenterol Hepatol

Abstract:

Background: A lot of reports have shown that patients with body mass index (BMI)>35kg/m2 who underwent metabolic surgery experienced resolution of type 2 diabetes (T2DM). One of those bariatric surgery proved to be safe, effective, reliable and reversible is Mini-gastric bypass (MGB). Little studies addressed the efficacy of MGB on the resolution of T2DM in patients with BMI< 35 kg/m2. Objectives: We aimed to evaluate the efficacy of MGB on resolution of T2DM in patients with BMI< 35 kg/m2. Methods: From March 2011 to May 2015; 135 patients with T2DM and BMI<35 kg/m2 underwent MGB were enrolled in this study. The changes in fasting blood sugar (FBS), glycosylated haemoglobin (HbA1c), alanine transaminase (ALT), C-peptide, total body weight and the use of oral hypoglycemic agents and insulin at the end of one year were studied. Results: 108 patients (80 %) showed resolution, 25 patients (18.5 %) showed remission and only two patients (1.5 %) failed to respond after surgery as shown in fig1. There was statistically significant changes in BMI, FBS, and HbA1c (fig 2) one year post operatively with p-value<0.05. The duration of T2DM, preoperative treatment, ALT, and C-peptide seem to be of paramount importance as prognostic factors for resolution of T2DM after surgery. Conclusion: Our study showed that MGB is associated with a high rate of resolution of T2DM at 12 months after surgery in diabetic patients

Biography :

Waleed Gado has completed his master’s degree in Surgery in 2008, PhD in 2014 from Mansoura University, Egypt. He is currently an Assistant Professor of Endocrine and Bariatric/ Metabolic Surgery. He is also a Consultant Surgeon in Egypt and Arab Gulf countries. His interest and research is mainly focused on minimally invasive approaches for endocrinal diseases and bariatric surgeries.

E-mail: waleedgado79@gmail.com